Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Contineum Therapeutics, Inc. - Common stock (NQ: CTNM ) 19.49 +0.58 (+3.07%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Contineum Therapeutics, Inc. - Common stock Contineum Therapeutics to Present at Multiple Upcoming Investor Conferences August 28, 2024 From Contineum Therapeutics, Inc. Via Business Wire CTNM Stock Earnings: Contineum Therapeutics Misses EPS for Q2 2024 August 13, 2024 CTNM stock results show that Contineum Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Contineum Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights August 13, 2024 From Contineum Therapeutics, Inc. Via Business Wire Contineum Therapeutics Announces Publication of Encouraging Data in the Proceedings of the National Academy of Sciences on PIPE-307, Its M1 Receptor Selective Inhibitor, in Clinical Development for Relapse-Remitting Multiple Sclerosis July 31, 2024 From Contineum Therapeutics, Inc. Via Business Wire Contineum Therapeutics Announces Appointment of Sarah Boyce to Board of Directors June 24, 2024 From Contineum Therapeutics, Inc. Via Business Wire Contineum Therapeutics to Present at the 45th Annual Goldman Sachs Healthcare Conference June 04, 2024 From Contineum Therapeutics, Inc. Via Business Wire Contineum Therapeutics Announces Appointment of John Healy as General Counsel & Corporate Secretary June 03, 2024 From Contineum Therapeutics, Inc. Via Business Wire Contineum Therapeutics Announces Appointment of Troy Ignelzi to Board of Directors May 20, 2024 From Contineum Therapeutics, Inc. Via Business Wire Contineum Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights May 16, 2024 From Contineum Therapeutics, Inc. Via Business Wire Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 16, 2024 Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates. Via Benzinga UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday April 16, 2024 U.S. stocks were mostly higher, with the Dow Jones index gaining over 100 points on Tuesday. Via Benzinga Topics Stocks Exposures US Equities Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.